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The  possibility  that  the  third  component  of complement,  C3,  might  regulate 
immune responses and other specific activities of lymphocytes was suggested initially 
by the effects on lymphocyte function of complement depletion in vivo (1)  and the 
introduction of C3 in vitro (2-5). C3 and partially purified C3a, the fragment of C3 
that exhibits anaphylatoxin activity (6), inhibit the transformation of rat and human 
lymphocytes incubated with mitogenic lectins in serum-free medium, as assessed by 
suppression of the increased lymphocyte uptake of [~H]thymidine (5, 7). Analyses of 
the cellular specificity of partially purified C3a have indicated that the proliferative 
responses of rat  B  lymphocytes are  more susceptible to inhibition  than  those of T 
lymphocytes (7).  Both purified human  C3a and the synthetic octapeptide C3a(70- 
77), which retains the activities of an anaphylatoxin (6, 8), now are shown to interact 
directly with human lymphocytes, as evidenced both by selective inhibition of the T 
lymphocyte migration and lymphokine generation elicited by diverse stimuli and by 
the  reduced lymphokine-generating activity of lymphocytes exposed to solid-phase 
C3a(70-77). 
Materials and Methods 
Medium 199, Hanks' balanced salt solution, Eagle's minimal essential medium, a MASH II 
cell harvester (M. A. Bioproducts,  Walkersville, MD), activated CH-Sepharose 4B, Sephadex 
G-10, 25,  75, and  100, SP-Sephadex,  QAE-Sephadex, macromolecular dextran (Macrodex), 
and Ficoll-Hypaque (Pharmaeia Fine Chemicals,  Div. of Pharmacia Inc., Piscataway,  N  J), 4- 
(2-hydroxyethyl)-1-piperazine-ethanesulfonie  acid (Hepes), penicillin  G, streptomycin (Gibco 
Laboratories,  Grand Island  Biological Co., Grand Island,  NY), five times recrystallized  oval- 
bumin, concanavalin A (Con A) 1 (Miles Laboratories, Inc., Elkhart, IN), phytohemagglutinin- 
M (PHA) (Difeo Laboratories,  Inc., Detroit, MI), streptokinase-streptodornase  (SK-SD) (Led- 
erie Laboratories  Inc., Pearl River, NY), a-thioglycerol (Sigma Chemical Co., St. Louis, MO), 
Drummond glass capillary tubes (Bolab, Inc., Derry, NH), murine monoclonal antibodies to 
human leukocyte surface antigens  (Ortho Diagnostics, Inc., Westwood, MA) (9), MacKaness- 
type plastic  chambers  (Adaps, Inc.,  Dedham,  MA),  [nH]thymidine  (New England Nuclear, 
Boston, MA), 3-/~m pore and 8-/zm pore membrane filters (Sartorius Filters, Hayward, CA), 8- 
/~m channel filters (Nuclepore Corp., Pleasanton, CA), and chemotactic chambers with a 0.2- 
ml blind-end stimulus compartment (Neuroprobe, Inc., Bethesda, MD) were obtained from the 
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specified suppliers. 
Chemotactic fragments of the fifth component of human complement (C5fr) were purified 
from zymosan=activated human  serum as described (10).  C3a was generated by incubating 
fresh human serum with  10 mg/ml of zymosan in the presence of 1 M  e-amino-caproic acid 
and purified by sequential filtration on Sephadex G-100 in 0.1  M  ammonium  formate  (pH 
5.0), ion-exchange chromatography on SP-Sephadex and QAE-Sephadex, and gel filtration on 
Sephadex G-75 in 0.05  M  ammonium  formate  (pH  5.0)  (11).  The C3a was quantified by a 
standard  protein  assay  (Bio-Rad  Laboratories,  Richmond,  CA),  its  capacity  to  contract 
segments of guinea pig ileum, and reactivity with monospecific anti-human C3 in a standard 
immunodiffusion assay (6,  11). The octapeptide Ala-Ser-His-Leu-Gly-Leu-Ala-Arg,  C3a(70- 
77), was prepared by standard solid-phase synthesis techniques and purified by filtration on 
Sephadex G-25 in 0.01  M  acetic acid and counter-current distribution (12).  C3a(70-77)  was 
coupled by the terminal amino-group to CH-Sepharose 4B by reacting 1 g of activated CH- 
Sepharose 4B with 10 gmoles of C3a(70-77)  in 5 ml of 0.5 M  NaCI-0.1 M  NaHCO3  (pH 7.4) 
for 1 h at room temperature under a N2 atmosphere. The product was washed twice with 200 
ml each of 1 M NaC1-0.1  M sodium acetate (pH 4.0), 1 M NaC1-0.1  M Tris-HC1 (pH 8.0), and 
distilled water and stored in 0.01  M  acetic acid at 4°C under N2 for up to  1 wk. Amino acid 
analyses of portions of the gel that had been hydrolyzed for 8 h at 160°C in propionic acid:HC1 
(1 : 1  ; vol/vol) indicated a coupling of 2.6-2.8 gmoles of C3a(70-77) per ml of CH-Sepharose 4B 
(range, n =  3). CH-Sepharose to which had been coupled the same quantity of glycine served 
as the adsorbent in control columns. 
Isolation of Human Leukocytes.  Leukocytes from normal donors were obtained and processed 
under sterile conditions for the production and quantification of leukocyte inhibitory factor 
(LIF) activity in the glass capillary tube assay and the assessment of lymphocyte proliferation. 
After dextran sedimentation of the erythrocytes in heparinized blood, the mixed leukocytes in 
the  plasma were  sedimented by  centrifugation,  washed,  and  resuspended  in  medium  199 
containing  25  mM  Hepes  (pH  7.4),  penicillin (100  U/ml),  and  streptomycin  (100  /xg/ml) 
(M199-HPS)  (13).  10-ml portions of 2  ×  106  leukocytes/ml were  layered on  10-ml  Ficoll- 
Hypaque cushions (sp gr, 1.076) and centrifuged at 500 g for 35 min at room temperature (13). 
The mononuclear leukocytes at the buffer-gradient interface were harvested and washed twice 
in M199-HPS. The polymorphonuclear leukocytes (PMN) in the pellet were resuspended in 1 
ml  of AB-positive human  serum  that  was  diluted  to  10  ml  with  distilled water  at  room 
temperature to lyse contaminating erythroeytes. After 20 s, 40 ml of M199-HPS was added, 
and the PMN were recovered by centrifugation and washed twice with M 199-HPS. The purity 
of the preparations was >95% for the PMN and >93% for the mononuclear leukocytes. 
PMN and T lymphocytes for studies of leukocyte migration in the modified Boyden chamber 
assay were isolated from citrate-anticoagulated venous blood of normal subjects, as described 
(10,  14). The mixed leukocytes were incubated in 0.84 g/100 ml NH4C1 with 0.01  M  NaHCO3 
(pH 7.2) for 2 min at room temperature to lyse contaminating erythroeytes, washed, resuspended 
in Hanks' solution containing 0.2 g ovalbumin/100 ml (HBSS-OA) and centrifuged on cushions 
of Ficoll-Hypaque to yield PMN of>95% purity and mononuclear leukocytes (15). The PMN 
were  washed  and  resuspended  in  HBSS-OA.  5-ml  portions  of the  suspension  of 4  ×  l07 
mononuclear leukocytes/ml in Eagle's medium with 0.2 g ovalbumin/100 ml were each applied 
to a  column of 10 ml of Sephadex G-10 on  5  ml of nylon wool that  was equilibrated and 
developed with 45  ml of the same medium. The  leukocytes in  the effluent were 92-96% T 
lymphocytes (range,  n  =  6),  as  assessed by quantifying the  rosetting of sheep  erythrocytes 
without and with surface C3b or C3d and by analyzing the surface immunoglobulins (14). For 
the preparation ofT lymphocytes for LIF studies, mononuelear leukocytes from Ficoll-Hypaque 
cushions were incubated with neuraminidase-treated fresh sheep erythrocytes to achieve roset- 
ring.  The  T  lymphocytes were  recovered  from  Ficoll-Hypaque cushions  after  lysis of the 
erythrocytes by hypotonic exposure, as described (16);  the purity of the T  lymphocytes always 
exceeded 95%. 
Purification and Quantification of LIF.  Replicate 2-ml suspensions of 6-8 ×  106 mononuclear 
leukocytes or purified T  lymphoeytes per ml  in  M199-HPS  containing  10%  (vol/vol)  AB- 
positive serum were cultured without or with 10/xg/ml of Con A, PHA, or SK-SD for 24 h at 
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C3a(70-77)  was added to cultures at the same time as  the mitogen or antigen stimulus. The 
same  concentration of stimulus  was  added  to  control  cultures  at  24  h,  immediately before 
centrifugation  of all  of the  cultures  at  1,050 g  for  10  rain  at  room  temperature  to  obtain 
leukocyte-free supernatants. 
Sterile suspensions  of PMN  were  washed  and  resuspended  in  6  volumes of M199-HPS 
containing  15%  (vol/vol) AB-positive human  serum.  20-#1 sterile glass  capillary tubes  were 
filled with the PMN suspension, centrifuged, cut at the level of the PMN pellet, and placed in 
duplicate on glass cover slips  in MacKaness-type plastic chambers that were filled with LIF- 
containing or control supernatant and incubated for 8 h at 37°C (13, 17). The area of migration 
of PMN from each capillary tube was quantified by projection microscopy and planimetry, as 
described (13), and the LIF activity in stimulated'supernatants was calculated by the formula: 
mean percent inhibition of migration =  1 -  ([mean area of migration from four capillaries in 
supernate of stimulated cultures]/[mean area of migration from four capillaries in supernate of 
control cultures])  ×  100. 
PMN chemotaxis was assessed in modified Boyden chambers with C5fr as the stimulus, and 
the responses  were quantified by microscopic counting of the PMN in fixed and stained filters, 
as described (10, 17). Chemotactic responses were expressed as mean net PMN per high-power 
field after subtraction of the mean value for filters of chambers lacking C5fr. To measure the 
activity of LIF, PMN were incubated for 10 min at 37°C with 1A0 dilutions ofsupernatant from 
stimulated  and  control cultures  before adding  the leukocytes to  the chemotactic chambers. 
Mean percent inhibition of migration in duplicate chambers was calculated as for the capillary 
tube method. The mean percent inhibition of migration by supernatants with C3a or C3a(70- 
77) was corrected for the level of inhibition observed when the same concentration of peptide 
alone was added to the assay, which never exceeded 20% in the capillary tube method or 5% in 
the chemotactic method. 
Assessment of Lymphocyte Proliferation.  2  ×  105 mononuelear leukocytes in 0.2  ml of M199- 
HPS containing 15%  (vol/vol) AB-positive serum were added to each well of microtiter plates 
without or with  10 #g/ml of Con A, PHA, or SK-SD and incubated at 37°C in 5% CO2:95% 
air. C3a or C3a(70-77)  was introduced into some suspensions at the same time as the stimulus 
or buffer.  After 3  d  for the  mitogen-stimulated cultures  and  5  d  for the  SK-SD-stimulated 
cultures,  1/zCi of [aH]thymidine was added to each well. After an additional  16 h at 37°C, the 
uptake of [aH]thymidine was analyzed by aspirating the contents of each well with a Mash II 
harvester that collected and washed the leukocytes on glass fiber filters,  as described (18). The 
radioactivity in each  filter was quantified, and  the results for quadruplicate chambers  were 
expressed  as  mean  cpm  +  SEM.  The  percentage  inhibition  of  lymphocyte  uptake  of 
[aH]thymidine  by  C3a  or  C3a(70-77)  was  calculated  from  the  ratio  of the  net  uptake  of 
radioactivity of stimulated lymphocytes in the presence of peptide to that  in  the absence of 
peptide (5). 
Measurement of T Lymphocyte Migration.  T  lymphocyte migration was quantified in modified 
Boyden chambers. The upper compartment of each chamber, containing 0.5 ml of a suspension 
of 5-6  ×  10  s  T  lymphocytes  in  HBSS-OA,  was  separated  from  the  lower  compartment 
containing 0.2 ml of HBSS-OA by a layer consisting of an 8-/~m pore Nuclepore filter over an 
8-/zm pore Sartorius filter (14). C3a or C3a(70-77) without or with Con A or a-thioglycerol was 
added at equal concentrations to both compartments, and the chambers were incubated for 4 
h at 37°C in 5% CO2:95% air. The T lymphoeytes that migrated in the front at 60-80 #m from 
the cell source were enumerated in 10 high power fields in filters from duplicate chambers. The 
migration of T  lymphocytes in the presence of C3a or C3a(70-77)  is expressed as a percent of 
that in buffer or a stimulus alone. The levels of significance of the differences in all assays were 
analyzed by the standard Student's t test. 
Results 
Inhibition  of the  Generation of LIF Activity  by  C3a  and  C3a(70-77).  Incubation  of 
normal human mixed mononuclear leukocytes with the mitogens PHA and Con A or 
the antigen SK-SD for 24 h  at 370C resulted in the generation of substantial levels of 
LIF activity, as  assessed  by  the  capacity of the  culture  supernatants  to  inhibit  the D.  G.  PAYAN,  D.  E.  TRENTHAM,  AND  E.  J.  GOETZL  759 
migration of human PMN from glass capillary tubes (Figs.  1-3). The introduction of 
C3a or C3a(70-77)  into the mononuclear leukocyte cultures along with the mitogen 
or antigen at the onset of incubation resulted in a  peptide concentration-dependent 
inhibition of the generation of LIF activity, irrespective of the stimulus. The extent of 
suppression  of the  generation  of LIF activity was  significant  at  concentrations of 
C3a(70-77) of 10  -7 M or greater for each of the stimuli and exceeded 75% suppression 
at  10  -6  M  C3a(70-77)  (Figs.  1-3).  The  concentration  of C3a(70-77)  required  to 
achieve 50% inhibition of LIF generation  (ICso) was ~ 10  -s M  for Con A  and PHA 
and  10  -7 M  for SK-SD. The suppression by C3a of the generation of LIF activity by 
mononuclear leukocytes exhibited a  similar peptide concentration-suppression rela- 
tionship as that observed with C3a(70-77) for the mitogen stimuli (Figs.  1 and 2), as 
assessed  by  the  examination  of ICs0  values.  The  potency of C3a  was  more  than 
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FIG.  1.  Effect  of C3a and C3a(70-77)  on  the generation  of LIF  activity  by  human peripheral 
blood mononuclear leukocytes stimulated with PHA. LIF was quantified by the inhibition of human 
PMN migration from glass capillary tubes. Each bar and error bracket represents the mean +  SEM 
for the group of data points. Each P value indicates the level of significance of the difference between 
the samples with PHA and C3a or C3a(70-77) and those with PHA alone. 
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FIc.  2.  Effect  of C3a and C3a(70-77)  on  the generation  of LIF  activity by  human peripheral 
blood  mononuclear leukocytes stimulated with  Con A.  LIF was  quantified by the  inhibition  of 
human PMN migration from glass capillary tubes. Each bar and error bracket represents the mean 
+  SEM for the group of data points. Each P value indicates the level of significance of the difference 
between the samples with Con A and C3a or C3a(70-77) and those with Con A alone. 760 
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rio.  3.  Effect  of C3a  and C3a(70-77)  on  the generation  of LIF  activity by  human peripheral 
blood  mononuclear leukocytes stimulated with  SK-SD.  LIF was quantified by  the inhibition of 
human PMN migration from glass capillary tubes. Each bar and error bracket represents the mean 
+  SEM for the group of data points. Each P value indicates the level of significance of the difference 
between the samples with SK-SD and C3a or C3a(70-77)  and those with SK-SD alone. 
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FIG. 4.  Effect of C3a(70-77)  on  the  generation  of LIF activity by human  peripheral blood 
mononuclear  leukocytes as measured  by the inhibition  of human  PMN chemotaxis  to C5fr  in 
Boyden chambers. Each bar and bracket represents the mean :1: SEM for the group of data points. 
Each P value indicates the level of significance for the same comparisons as in Figs. 2 and 3. 
10-fold  higher  than  that  of  C3a(70-77)  with  respect  to  the  suppression  of  LIF 
generation evoked by the antigen SK-SD (Fig. 3).  Quantification of LIF activity by 
the inhibition of chemotaxis of PMN to C5fr in a Boyden chamber assay corroborated 
the results of the capillary tube assay for LIF, despite the greater inhibitory activity 
of LIF in the former assay (Fig. 4). The ICs0 for the suppression of LIF generation was 
~10 -s M  C3a(70-77)  with Con A  as the stimulus and was  10 -7 M  C3a(70-77)  with 
SK-SD, which were identical to the respective values obtained with the capillary tube 
assay. 
When C3a(70-77)  was added to the cultures either I h  before or after PHA or Con 
A, the extent of suppression of the generation of LIF activity elicited by either mitogen 
was not significantly different from the results in the standard experimental protocol, 
where the mitogen and C3a(70-77)  were added together at the beginning of the 24-h 
incubation  interval. That  the suppressive effect of C3a and  C3a(70-77)  was  attrib- D. G.  PAYAN, D.  E.  TRENTHAM, AND E. J.  GOETZL  761 
utable to inhibition of the generation or release of LIF, rather than interference with 
the expression of LIF activity, was demonstrated by two separate approaches. First, 
the addition of 10  -9 M  to  10  -8 M  C3a(70-77)  or of 10  -8 M  to  10  -8 M  C3a to LIF- 
containing supernatants after removal of the mononuclear leukocytes did not diminish 
the  LIF activity  detected  in  either  the  capillary  tube  or  Boyden chamber  assay. 
Second, the amount of LIF recovered by gel filtration from supernatants of cultures 
stimulated by mitogen without or with C3a(70-77) was directly proportional to the 
quantity found by assays of the unpurified supernatants before the resolution of LIF 
from C3a(70-77).  Two sets  of duplicate  supernatants  were  prepared  from 2  ×  108 
mononuclear leukocytes in 60 ml of M199-HPS containing  10% AB-positive serum 
and  10  gg/ml  of  PHA,  one  set  of  which  contained  10  -6  M  C3a(70-77).  The 
supernatants were lyophilized, redissolved in 3 ml of distilled water, dialyzed against 
distilled water for 24 h at 4°C, and filtered on a column of Sephadex G-100 that was 
equilibrated  and developed with  M199-HPS as described  (17).  The portions of the 
effluent  that  contained  LIF  activity  were  pooled  and  concentrated  by  pressure 
filtration  (Amicon, Inc.,  Bedford,  MA)  to  3  ml.  The  LIF activity  detected  by the 
capillary tube method was 43 +  3%  (mean -+_ SEM)  for the set without C3a(70-77) 
and  16 +  2% for the set  with  10  -6 M  C3a(70-77)  before the removal of C3a(70-77) 
by gel filtration. The respective values were 40 +  2% and 20 +  2% for a  V100 dilution 
of the pools of LIF after gel filtration. 
In  two  experiments  with  T  lymphocytes purified  by  the  erythrocyte rosetting 
technique,  the  LIF activity  elicited  by  10  gg/ml  of PHA  induced  20%  and  20% 
inhibition of PMN migration from glass capillary tubes, which was suppressed to  1% 
and -10%, respectively, by 10  -8 M  C3a(70-77). 
Inhibition of TLymphocyte  Migration by C3a(70-77).  The addition of 10  -9 M  to 10  -6 
M  C3a(70-77)  to purified human T  lymphocytes suppressed the enhanced random 
migration  elicited  by  1 gg/ml  of  Con  A  and  3  ×  10  -n  M  a-thioglycerol  in  a 
concentration-dependent manner (Table I). The extent of inhibition of T  lymphocyte 
migration was significant at or above concentrations of C3a(70-77) of 3 ×  10  -9 M  for 
the Con A stimulus and of 10  -9 M  for a-thioglycerol. The ICs0 for C3a(70-77)was ~3 
×  10  -8 M  with Con A and  10  -8 M  with a-thioglycerol. 
Lack of Effect  of C3a and C3a(70-77)  on Lymphocyte Proliferation and  Viability.  The 
addition of 10  -8 M  to  10  -n M  C3a(70-77) or 10  -8 M  and  10  -7 M  C3a to suspensions 
of mononuclear leukocytes without or with PHA, Con A, or SK-SD at the beginning 
TABLE I 
Inhibition of Human T Lymphocyte Migration by C3a (70-77) 
Concentration  of C3a(70-77),  molar 
Stimulus of  3  ×  10 -9  3  X  10 -9  10 -s  3  ×  10 -a  10 .7  3  ×  10 -7  10 .6 
migration  10 -~° 
Percentage of control-stimulated  migration 
mean  +. SD; n  =  3 
ConA  --  90±8  76+  11"  57+  12"  49±  10"  44+  11"  --  -- 
a-thioglycerol  96+3  83±2"  72:1:4"  53±5"  43+5"  39:t:8"  33±6"  26±4" 
The  level of statistical significance of the  inhibition of migration by C3a(70-77) relative to  the 
corresponding control stimulated migration of T lymphocytes  in the absence of C3a(70-77) (100%) is 
denoted by an asterisk; P < 0.01. 762  C3a EFFECTS ON HUMAN LYMPHOCYTES 
of the  incubation  period  failed  to  suppress  significantly  the  level  of  uptake  of 
[~H]thymidine (Table II). The incubation of mononuelear leukoeytes with  10  -n M 
C3a or 10  -6 M  C3a(70-77) for 2-12 h  failed to reduce the viability of the leukocytes 
below that of those in medium alone, as assessed by the exclusion of trypan blue dye 
and the level of uptake of [ZH]thymidine in culture. 
Adsorption of LIF-producing  Mononuclear Leukocytes on C3a (70-77)-Sepharose.  To exam- 
ine the interaction of mononuclear leukocytes with C3a(70-77) more directly, identical 
aliquots  of suspensions  of mononuclear leukocytes were  filtered over a  column  of 
Sepharose to which had been coupled C3a(70-77) and a control column of Sepharose 
bearing the same molar quantity of glycine. The mean levels of LIF activity generated 
by Con A stimulation of leukocytes in the effluent from control Sepharose columns 
were 42%, 26%, and 32% inhibition of PMN migration, respectively, in three separate 
experiments,  whereas  the  LIF  activity  generated  by  Con  A  stimulation  of  the 
mononuclear leukocytes in  the effluents from C3a(70-77)-Sepharose columns were 
0%, -10%, and -14%. In each of the three experiments, one-half of the leukocytes in 
the effluents from the C3a(70-77)-Sepharose column and  from the control column 
were mixed together before stimulation with Con A. The mean levels of  LIF generation 
were 36%,  35%, and 39% inhibition of PMN migration, which were not significantly 
different from the levels observed with the same number of mononuclear leukocytes 
from  control  columns.  In  addition,  10  -n  M  C3a(70-77)  suppressed  the  levels  of 
generation of LIF activity to 9 +  9% (mean +  SEM; n =  3; P <  0.07) for leukocytes 
from control columns and to 4 +  7% (P <  0.01)  for the mixtures of leukocytes from 
control and C3a(70-77)-Sepharose columns.  The viability of the mononuclear leu- 
kocytes in the effluents ranged from 80-85% for all column procedures, as assessed by 
the exclusion of trypan blue dye, and the recovery ranged from 85-90%. 
The distribution  of subclasses of T  lymphocytes in  the column effluents for two 
consecutive experiments was analyzed in a  fluorescence-activated cell sorter (Ortho 
Spectrum III; Ortho Diagnostic Systems, Westwood, MA) with standardized mouse 
monoclonal  antisera  to  human  leukocyte  antigens  (9).  The  subpopulations  of T 
lymphocytes in  the  effluents from  the  control-Sepharose column  were  41.9%  and 
52.2%  OKT4, 67.7%  and  82.1% OKT3, and  34.2%  and  24.3%  OKT8,  and  in  the 
TABLE II 
Effect of C3a and C3a (70-77) on the Proliferative Responses of Human Blood Mononuclear Leukocytes 
C3a(70-77)  C3a  Stimulus  PHA  (6)*  Con A  (8)  SK-SD  (7) 
% inhibi-  % inhibi- 
mean cpm + SEM  tmn~  mean epm + SEM  tion~  mean cpm + SEM 
--  --  --  400 +  36  580 +  118  2,843 +  897 
10-* M  --  --  372 ±  41  674 +  129  2,640 +  1,000 
10  -7 M  --  --  452 ±  62  609 +  104  2,610 :l:  1,048 
10  n M  --  --  369 -1- 32  580+  104  2,886:1:968 
--  10  -8 M  --  712 +  186  930 -1- 251  4,246 ±  1,413 
--  10  -7 M  618 +  92  1,258 +  327  3,450 ±  1,052 
--  --  +  214,195 +  5,093  107,417 +  5,868  41,274 +  15,85l 
10  -a M  --  +  205,446 ±  8,762  5  ±  3  88,289 +  4,916  7 +  2  35,532 +  13,892 
10  7M  --  +  224,289+  7,831  0  101,477+4,190  6±2  37,798±  14,992 
106M  --  +  212,635±11,279  4±4  102,652+5,870  6±3  39,734+18,569 
--  10-aM  +  214,160  +  10,213  5+3  97,776+5,431  10+4  33,069+14,150 
--  10  -r M  +  201,225  ±  19,917  10 ±  8  96,681  +  6,526  12 ±  6  32,675 ±  15,328 
% inhibz- 
lion 
24±9 
11±5 
21+8 
32 ±  12 
39±  15 
* The  number of experiments performed  is indicated  in parentheses. 
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respective effluents from the C3a(70-77)-Sepharose column were 36.6% and  44.1% 
OKT4, 69.5% and 80.6% OKT3, and 33.8% and 22.7% OKT8. The subpopulations 
of T  lymphocytes in the effluents from control columns were not different from those 
found in the circulation  (9).  Thus, the interaction of mononuclear leukocytes with 
solid-phase C3a(70-77) resulted in a relative depletion of the helper/inducer subpop- 
ulation (OKT4), without significant alterations in the suppression/cytotoxic subpop- 
ulation (OKT8) or in the overall representation of lymphocytes (OKT3). 
Discussion 
Diverse activities of lymphocytes are regulated with a high degree of specificity by 
numerous immunological mediators other than antigens and antibodies.  Definitive 
characterization of the mechanisms of such lymphocyte responses requires the use of 
structurally defined principles. The direct interaction of purified C3a and C3a(70- 
77)  with  human  mononuclear  leukocytes  in  culture  resulted  in  a  concentration- 
dependent inhibition of the generation of LIF evoked by mitogens and by the antigen 
SK-SD (Figs.  1-4). The extent of suppression of LIF generation by C3a(70-77)  was 
significant  at  concentrations of  10  -7  M  or  higher  and  exceeded  75%  at  10  -6  M, 
irrespective of the stimulus. The same C3a(70-77) concentration-inhibition relation- 
ships were obtained whether LIF was quantified with the capillary tube assay or a 
modified  Boyden chamber  method.  That  C3a(70-77)  was  capable  of suppressing 
distinct immunological activities of isolated human T  lymphocytes was demonstrated 
by two separate approaches, although an action on mononuclear phagocytes has not 
been  excluded.  First,  the  generation  of LIF  by  T  lymphocytes  purified  with  an 
erythrocyte rosetting technique was  inhibited  by  10  -s  M  C3a(70-77)  to  a  similar 
degree  as  the  generation  of LIF  by  mixed  mononuclear  leukocytes.  Second,  the 
migration ofT lymphocytes stimulated by Con A or by a-thioglycerol was suppressed 
significantly by C3a(70-77). The ICs0 of 3 ×  10  -s M  C3a(70-77) with Con A as the 
stimulus  for  migration  (Table  I)  was  similar  to  the  ICs0  of  10  -s  M  C3a(70-77) 
observed for the generation of LIF elicited by Con A  (Fig. 2). 
The  inhibitory  effects  of C3a  on  lymphocytes  exhibited  both  functional  and 
molecular specificity. At concentrations that suppressed maximally the generation of 
LIF, neither C3a nor C3a(70-77) inhibited significantly the proliferative responses of 
mononuclear  leukocytes to  mitogens  or  antigen  (Table  II).  Although  C3a(70-77) 
retains only 1-2% of the potency of intact C3a with respect to anaphylatoxin activity 
(6, 9), the generation of LIF by mononuclear leukocytes and T  lymphocytes cultured 
with  mitogens was  suppressed  similarly by synthetic C3a(70-77)  and  purified C3a 
(Figs.  1, 2). In contrast, the potency of C3a was more than  10-fold higher than that 
of C3a(70-77) in terms of the suppression of LIF generation by mononuclear leuko- 
cytes (Fig. 3) and T  lymphocytes cultured with the antigen SK-SD. If it is assumed 
that  the  capacity of C3a  to  distinguish  between  antigen-  and  mitogen-stimulated 
lymphocytes is not a  function of other factors contaminating the C3a preparation, 
then it may be concluded that the regulatory effects of C3a reside in more than one 
molecular domain. Only amino acids 70-77 are required for optimum modulation of 
lymphokine production by mitogen-stimulated  lymphocytes, whereas  one or more 
other domains of C3a might need to be presented to antigen-stimulated lymphocytes 
for maximum inhibitory potency. 
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critical  to  the  generation  of lymphokines was  demonstrated  by  the  failure of the 
lymphocytes in the column effluent to generate LIF when challenged with Con A. 
That the loss of LIF-generating activity was not a  function of the production of an 
inhibitory factor was proven by the findings of similar levels of LIF in supernatants 
from control lymphocytes and from mixtures composed of an equal number of control 
lymphocytes and  of lymphocytes passed  through  a  C3a(70-77)-Sepharose  column. 
The data presented do not definitively exclude the possibility that the LIF-generating 
lymphocytes were inactivated, but not adsorbed, on the C3a(70-77)-Sepharose col- 
umn. 
The secondary antibody responses of rat lymph node cells to both thymus-depend- 
ent and thymus-independent antigens in vitro were inhibited by purified human C3 
and  fragments of C3  that  resembled C3a  in molecular weight  (7).  The suppressive 
effect of C3  and  the C3a-like  fragments was  not  attributable  to alterations  in  the 
kinetics  of antibody  production  or  to  the  induction  of suppressor  populations  of 
lymphocytes or macrophages, which suggested the possibility of an action of C3a on 
B lymphocytes. However, the capacity of highly purified human C3a to inhibit the 
production of antibodies by mouse lymphocytes was not dependent on the suppression 
of B  lymphocyte proliferation,  a  finding  that  implies  that  C3a  may  modify  the 
function of one or more regulatory subsets ofT lymphocytes (19). The reduced ability 
of human T  lymphocytes to generate lymphokines in the presence of C3a or C3a(70- 
77),  irrespective of the nature  of the stimulus,  and  the removal or inactivation by 
solid-phase C3a(70-77) of the lymphocytes required for LIF generation provide direct 
evidence  for  functional  modulation  of T  lymphocyte-dependent cellular  immune 
phenomena by a product of the complement cascade. 
Summary 
Human C3a and the synthetic octapeptide C3a(70-77), which retains the activities 
of an anaphylatoxin, inhibit in a concentration-dependent manner the generation of 
leukocyte i~hibitory factor (LIF) activity by human mononuclear leukocytes and T 
lymphocytes cultured with the mitogens phytohemagglutinin (PHA) or concanavalin 
A  (Con A)  or the antigen streptokinase-streptodornase (SK-SD). The generation of 
LIF activity was inhibited by 50% by 10  -8 M  C3a or C3a(70-77) with PHA or Con 
A as the stimulus, whereas a  more than  10-fold higher concentration of C3a(70-77) 
than C3a was required to achieve the same level of suppression with SK-SD as the 
stimulus.  Similar  concentrations  of C3a(70-77)  inhibited  to  the  same  extent  the 
migration of T  lymphocytes stimulated by a-thioglycerol or Con A. Neither C3a nor 
C3a(70-77) altered significantly the uptake of [3H]thymidine by human mononuclear 
cells exposed to PHA, Con A, or SK-SD. The capacity of C3a(70-77)-Sepharose, but 
not Sepharose alone, to adsorb or inactivate mononuclear leukocytes required for the 
generation of LIF activity established a direct interaction. Analysis of the lymphocytes 
in the effluent from C3a(70-77)-Sepharose columns, using monoclonal antibodies to 
surface antigens,  showed  a  selective depletion of the  helper/inducer population  of 
lymphocytes. C3a might represent an important mediator of the functionally selective 
regulation of human T  lymphocyte activities by the complement system. 
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